Sarah Cannon Development Innovations
Sarah Cannon Development Innovations is a full-service contract research organization (CRO) that is uniquely focused in oncology. Sarah Cannon Innovations offers strong scientific leadership, access to patients through Sarah Cannon Research Institute’s Site Management Organization (SMO) and relationships with other clinical sites, and experience in drug development and delivery of clinical trials from First-In-Man through registration level studies, making us the partner of choice for oncology.
Our differentiator is strong operational delivery in partnership with our Site Management Organization and physician leaders to deliver your program efficiently.
Sarah Cannon Development Innovations works with Sarah Cannon Research Institute strategic and network sites throughout the United States, along with investigators at sites outside of the Sarah Cannon Research Institute network. This reach allows Sarah Cannon Development Innovations to offer sponsors access to a diverse and varied patient population, spanning multiple tumor types and disease stages. These relationships further enhance the depth and breadth of Sarah Cannon Development Innovations’ therapeutic expertise, enabling it to provide focused, strategic operational support. This support ensures that clinical trials are conducted in a timely manner and reported with high-quality, registration-standard data.
Our differentiator is strong
- True Partnership
- Partnership Models
- Proven Processes
- Quality Delivery
- Molecular Profiling
- Outcomes Research
Sarah Cannon Development Innovations Value
- Full-service CRO capabilities with stand-alone functional expertise
- Early-phase oncology experts
- Practicing MD study chair
- Quality delivery with flexibility
- Expansive patient outreach
- SMO Relationship
- Global capabilities
- Sponsor endorsed